Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathwayXiaoping Duan, Zhichao Zhou, Shu-Fang Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastasesShu-Fang Jia, Laura L Worth, Charles L Densmore, et al.
Cancer Gene Therapy|April 19, 2002
Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16Rong-Rong Zhou, Shu-Fang Jia, Zhichao Zhou, et al.
Clinical & Experimental Metastasis|July 23, 2005
Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cellsXiaoping Duan, Shu-Fang Jia, Zhichao Zhou, et al.
Cancer Gene Therapy|March 16, 2002
Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vectorShu-Fang Jia, Laura L Worth, Charles L Densmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabineNancy Gordon, Nadezhda V Koshkina, Shu-Fang Jia, et al.
International Journal of Cancer|June 10, 2008
Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factorKrishna Reddy, Zhichao Zhou, Shu-Fang Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Increased Fas expression reduces the metastatic potential of human osteosarcoma cellsElizabeth A Lafleur, Nadezhda V Koshkina, John Stewart, et al.
Cancer Research|March 1, 2005
Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcomaYing Cao, Zhichao Zhou, Benoit de Crombrugghe, et al.
Molecular Cancer Therapeutics|July 23, 2008
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcomaHui Guan, Zhichao Zhou, Gary E Gallick, et al.
Pageof 2